相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
Cheng-Xu Ma et al.
CARDIOVASCULAR DIABETOLOGY (2022)
Association of the Pro12Ala gene polymorphism with treatment response to thiazolidinediones in patients with type 2 diabetes: a meta-analysis
Johana Vallo et al.
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES (2022)
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Matthew J. Page et al.
INTERNATIONAL JOURNAL OF SURGERY (2021)
Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
Gaia Chiara Mannino et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis
Elena Filipova et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
Association of the variants in the PPARG gene and serum lipid levels: a meta-analysis of 74 studies
Qing Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
Zhanjun Jia et al.
PPAR RESEARCH (2014)
Adiponectin and lipoprotein metabolism
G. A. Christou et al.
OBESITY REVIEWS (2013)
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
David R. Whiting et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) Pro12Ala in the Iranian population: Relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes
Fatemeh Namvaran et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
The Association Between the Peroxisome Proliferator-Activated Receptor-γ2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis
Hebe N. Gouda et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Associations Between Lipid Measures and Metabolic Syndrome, Insulin Resistance and Adiponectin - Usefulness of Lipid Ratios in Korean Men and Women
Heejin Kimm et al.
CIRCULATION JOURNAL (2010)
Association of the PPAR gamma 2 gene Pro12Ala variant with primary hypertension and metabolic lipid disorders in Han Chinese of Inner Mongolia
L. Gao et al.
GENETICS AND MOLECULAR RESEARCH (2010)
Common polymorphisms of the peroxisome proliferator-activated receptor-γ (Pro12Ala) and peroxisome prolderator-activated receptor-γ coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus
Ming-Chia Hsieh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass
Bruno Geloneze et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2009)
Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men
Dick C. Chan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales
Julian P. T. Higgins et al.
STATISTICS IN MEDICINE (2008)
Arterial elasticity and plasma levels of adiponectin and leptin in type 2 diabetic patients treated with thiazolidinediones
Ozen Oz et al.
ENDOCRINE (2008)
Skeletal consequences of thiazolidinedione therapy
A. Grey
OSTEOPOROSIS INTERNATIONAL (2008)
Pharmacogenetics of thiazolidinedione therapy
Christina L. Aquilante
PHARMACOGENOMICS (2007)
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Takashi Kadowaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetes
ES Kang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
PPARs: therapeutic targets for metabolic disease
JP Berger et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Differential effects of the C1431T and Pro12Ala PPARγ gene variants on plasma lipids and diabetes risk in an Asian population
ES Tai et al.
JOURNAL OF LIPID RESEARCH (2004)
Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach
H Bays et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Analysis of the relationship between the pro12Ala variant in the PPAR-γ2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes
M Blüher et al.
DIABETES CARE (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
The mode of action of thiazolidinediones
H Hauner
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
Mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance.
T Yamauchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The pleiotropic functions of peroxisome proliferator-activated receptor gamma
MB Debril et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-γ 2 on thiazolidinedione-induced adipogenesis
J Masugi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
